Filtros

Buscador
Año
Sanchez-Beltran J, Soler Diaz J, Herraiz C, Olivares C, Cerdido S, Cerezuela-Fuentes P, Garcia-Borron JC, Jimenez-Cervantes C. An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival. Int J Mol Sci. 2025 Feb 18;26(4):1739. doi: 10.3390/ijms26041739. PubMed PMID: 40004203; PubMed Central PMCID: PMC11855888.
AÑO: 2025; IF: 4.9
Marquez-Rodas I, Dutriaux C, Saiag P, de la Cruz Merino L, Castanon Alvarez E, Robert C, Rodriguez-Moreno JF, Arance A, Cerezuela-Fuentes P, Montaudie H, Sanmamed MF, Gonzalez-Cao M, Charles J, Lopez Criado MP, Berrocal A, de Miguel E, Funck-Brentano E, Prey S, Alamo de la Gala MC, Melero I, Aviles-Izquierdo JA, Roman R, Garcia-Pelaez B, Rodriguez S, Trnkova ZJ, Quintero M, Macia S, Chaney MF, Dalle S. BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203. J Clin Oncol. 2025 Jun 27:JCO2402595. doi: 10.1200/JCO-24-02595. Online ahead of print. PubMed PMID: 40577656.
AÑO: 2025; IF: 42.1
Manzano JL, Martin-Liberal J, Fernandez-Morales LA, Benitez G, Medina Martinez J, Quindos M, Garcia-Castano A, Fernandez O, Simo RV, Majem M, Bellido L, Ayala de Miguel P, Campos B, Espinosa E, Macias Cerrolaza JA, Gil-Arnaiz I, Lorente D, Rodriguez-Lescure A, Perez VN, Lopez Castro R, Gramaje MG, Puertolas T, Rodriguez Moreno JF, Espasa Font L, Belaustegui Ferrandez G, Cerezuela-Fuentes P. Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study. Melanoma Res. 2023 Oct 1;33(5):388-397. doi: 10.1097/CMR.0000000000000888. Epub 2023 Mar 28. PubMed PMID: 36988401; PubMed Central PMCID: PMC10470432.
AÑO: 2023; IF: 1.5
Gonzalez-Cao M, Puertolas T, Martinez-Vila C, Carrera C, Maldonado Seral C, Rodriguez-Jimenez P, Sequero S, Cerezuela-Fuentes P, Feltes Ochoa R, Munoz E, Antonanzas Basa M, Martin-Liberal J, Soria A, Francisco Rodriguez Moreno J, Marquez-Rodas I, Lopez Criado P, Luis Manzano J, Lopez-Castro R, Ayala de Miguel P, Villalobos L, Martin Algarra S, Gonzalez-Barrallo I, Boada A, Garcia Castano A, Puig S, Crespo G, Luna Fra P, Aguayo Zamora C, Feito Rodriguez M, Valles L, Drozdowskyj A, Gardeazabal J, Antonio Fernandez-Morales L, Rodrigo A, Cruz R, Yelamos O, Rubio B, Mujica K, Provencio M, Berrocal A; Spanish Melanoma Group (GEM). SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry. Clin Transl Oncol. 2023 Mar;25(3):768-775. doi: 10.1007/s12094-022-02985-7. Epub 2022 Dec 24. PubMed PMID: 36566266; PubMed Central PMCID: PMC9789885.
AÑO: 2023; IF: 2.8
Pinero-Madrona A, Cerezuela-Fuentes P, Ruiz-Merino G, Martinez-Barba E, Ortiz-Reina S, Martinez-Ortiz MJ, Lopez-Avila A, Frias-Iniesta JF, Viney A, Cabezas-Herrera J. Lower limb cutaneous melanoma surgery: location matters. Arch Dermatol Res. 2023 Sep;315(7):1971-1978. doi: 10.1007/s00403-023-02571-z. Epub 2023 Mar 2. PubMed PMID: 36862181; PubMed Central PMCID: PMC10366258.
AÑO: 2023; IF: 1.8